TY - JOUR AU - Moinpour, C. M. AU - Savage, M. J. AU - Troxel, A. PY - 1998 DA - 1998// TI - Quality of life in advanced prostate cancer: results of a randomized therapeutic trial JO - J Natl Cancer Inst VL - 90 UR - https://doi.org/10.1093/jnci/90.20.1537 DO - 10.1093/jnci/90.20.1537 ID - Moinpour1998 ER - TY - JOUR AU - Hellman, S. AU - Weichselbaum, R. R. PY - 1995 DA - 1995// TI - Oligometastases JO - J Clin Oncol VL - 13 UR - https://doi.org/10.1200/JCO.1995.13.1.8 DO - 10.1200/JCO.1995.13.1.8 ID - Hellman1995 ER - TY - JOUR AU - Bacci, G. AU - Rocca, M. AU - Salone, M. PY - 2008 DA - 2008// TI - High grade osteosarcoma of the extremities with lung metastases at presentation: treatment with neoadjuvant chemotherapy and simultaneous resection of primary and metastatic lesions JO - J Surg Oncol VL - 98 UR - https://doi.org/10.1002/jso.21140 DO - 10.1002/jso.21140 ID - Bacci2008 ER - TY - JOUR AU - Simmonds, P. C. AU - Primrose, J. N. AU - Colquitt, J. L. AU - Garden, O. J. AU - Poston, G. J. AU - Rees, M. PY - 2006 DA - 2006// TI - Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies JO - Br J Cancer VL - 94 UR - https://doi.org/10.1038/sj.bjc.6603033 DO - 10.1038/sj.bjc.6603033 ID - Simmonds2006 ER - TY - JOUR AU - Fong, Y. AU - Cohen, A. M. AU - Fortner, J. G. PY - 1997 DA - 1997// TI - Liver resection for colorectal metastases JO - J Clin Oncol VL - 15 UR - https://doi.org/10.1200/JCO.1997.15.3.938 DO - 10.1200/JCO.1997.15.3.938 ID - Fong1997 ER - TY - JOUR AU - Steele, G. AU - Bleday, R. AU - Mayer, R. J. AU - Lindblad, A. AU - Petrelli, N. AU - Weaver, D. PY - 1991 DA - 1991// TI - A prospective evaluation of hepatic resection for colorectal carcinoma metastases to the liver: gastrointestinal tumor study group protocol 6584 JO - J Clin Oncol VL - 9 UR - https://doi.org/10.1200/JCO.1991.9.7.1105 DO - 10.1200/JCO.1991.9.7.1105 ID - Steele1991 ER - TY - JOUR AU - Deek, M. P. AU - Yu, C. AU - Phillips, R. PY - 2019 DA - 2019// TI - Radiation therapy in the definitive Management of Oligometastatic Prostate Cancer: the Johns Hopkins experience JO - Int J Radiat Oncol Biol Phys VL - 105 UR - https://doi.org/10.1016/j.ijrobp.2019.08.008 DO - 10.1016/j.ijrobp.2019.08.008 ID - Deek2019 ER - TY - JOUR AU - Iyengar, P. AU - Wardak, Z. AU - Gerber, D. E. PY - 2018 DA - 2018// TI - Consolidative radiotherapy for limited metastatic non-small-cell lung Cancer: a phase 2 randomized clinical trial JO - JAMA Oncol VL - 4 UR - https://doi.org/10.1001/jamaoncol.2017.3501 DO - 10.1001/jamaoncol.2017.3501 ID - Iyengar2018 ER - TY - JOUR AU - Gomez, D. R. AU - Blumenschein, G. R. AU - Lee, J. J. PY - 2016 DA - 2016// TI - Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study JO - Lancet Oncol VL - 17 UR - https://doi.org/10.1016/S1470-2045(16)30532-0 DO - 10.1016/S1470-2045(16)30532-0 ID - Gomez2016 ER - TY - JOUR AU - Palma, D. A. AU - Olson, R. AU - Harrow, S. PY - 2019 DA - 2019// TI - Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial JO - Lancet VL - 393 UR - https://doi.org/10.1016/S0140-6736(18)32487-5 DO - 10.1016/S0140-6736(18)32487-5 ID - Palma2019 ER - TY - JOUR AU - Phillips, R. M. AU - Hayman, J. AU - Tran, P. T. PY - 2018 DA - 2018// TI - STOMPing out hormone-sensitive metastases with local therapies in prostate Cancer JO - J Clin Oncol VL - 36 UR - https://doi.org/10.1200/JCO.2017.76.5495 DO - 10.1200/JCO.2017.76.5495 ID - Phillips2018 ER - TY - JOUR AU - Ost, P. AU - Reynders, D. AU - Decaestecker, K. PY - 2018 DA - 2018// TI - Surveillance or metastasis-directed therapy for Oligometastatic prostate Cancer recurrence: a prospective, randomized, multicenter phase II trial JO - J Clin Oncol VL - 36 UR - https://doi.org/10.1200/JCO.2017.75.4853 DO - 10.1200/JCO.2017.75.4853 ID - Ost2018 ER - TY - JOUR AU - Radwan, N. AU - Phillips, R. AU - Ross, A. PY - 2017 DA - 2017// TI - A phase II randomized trial of observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE) JO - BMC Cancer VL - 17 UR - https://doi.org/10.1186/s12885-017-3455-6 DO - 10.1186/s12885-017-3455-6 ID - Radwan2017 ER - TY - STD TI - Phillips R, Shi WY, Deek M, Radwan N, Lim SJ, Antonarakis ES, Rowe SP, Ross AE, Gorin MA, Deville C, Greco SC, Wang H, Denmeade SR, Paller CJ, Dipasquale S, DeWeese TL, Song DY, Wang H, Carducci MA, Pienta KJ, Pomper MG, Dicker AP, Eisenberger MA, Alizadeh AA, Diehn M, Tran PT. Outcomes of observation vs stereotactic ablative radiation for Oligometastatic prostate Cancer: the ORIOLE phase 2 randomized clinical trial. JAMA Oncol. 2020;6(5):650-9. PMID: 32215577. ID - ref14 ER - TY - JOUR AU - Soldatov, A. AU - Klot, C. A. J. AU - Walacides, D. PY - 2019 DA - 2019// TI - Patterns of progression after (68) Ga-PSMA-ligand PET/CT-guided radiation therapy for recurrent prostate Cancer JO - Int J Radiat Oncol Biol Phys VL - 103 UR - https://doi.org/10.1016/j.ijrobp.2018.08.066 DO - 10.1016/j.ijrobp.2018.08.066 ID - Soldatov2019 ER - TY - JOUR AU - Parker, C. AU - Nilsson, S. AU - Heinrich, D. PY - 2013 DA - 2013// TI - Alpha emitter radium-223 and survival in metastatic prostate cancer JO - N Engl J Med VL - 369 UR - https://doi.org/10.1056/NEJMoa1213755 DO - 10.1056/NEJMoa1213755 ID - Parker2013 ER - TY - JOUR AU - Deshayes, E. AU - Roumiguie, M. AU - Thibault, C. PY - 2017 DA - 2017// TI - Radium 223 dichloride for prostate cancer treatment JO - Drug Des Devel Ther VL - 11 UR - https://doi.org/10.2147/DDDT.S122417 DO - 10.2147/DDDT.S122417 ID - Deshayes2017 ER - TY - JOUR AU - Nilsson, S. AU - Franzen, L. AU - Parker, C. PY - 2007 DA - 2007// TI - Bone-targeted radium-223 in symptomatic, hormone-refractory prostate cancer: a randomised, multicentre, placebo-controlled phase II study JO - Lancet Oncol VL - 8 UR - https://doi.org/10.1016/S1470-2045(07)70147-X DO - 10.1016/S1470-2045(07)70147-X ID - Nilsson2007 ER - TY - JOUR AU - Nilsson, S. AU - Larsen, R. H. AU - Fossa, S. D. PY - 2005 DA - 2005// TI - First clinical experience with alpha-emitting radium-223 in the treatment of skeletal metastases JO - Clin Cancer Res VL - 11 UR - https://doi.org/10.1158/1078-0432.CCR-04-2244 DO - 10.1158/1078-0432.CCR-04-2244 ID - Nilsson2005 ER - TY - JOUR AU - Hobbs, R. F. AU - Song, H. AU - Watchman, C. J. PY - 2012 DA - 2012// TI - A bone marrow toxicity model for (2)(2)(3) Ra alpha-emitter radiopharmaceutical therapy JO - Phys Med Biol VL - 57 UR - https://doi.org/10.1088/0031-9155/57/10/3207 DO - 10.1088/0031-9155/57/10/3207 ID - Hobbs2012 ER - TY - JOUR AU - Vickers, A. J. PY - 2006 DA - 2006// TI - How to randomize JO - J Soc Integr Oncol VL - 4 UR - https://doi.org/10.2310/7200.2006.023 DO - 10.2310/7200.2006.023 ID - Vickers2006 ER - TY - JOUR AU - Cessna, J. T. AU - Zimmerman, B. E. PY - 2010 DA - 2010// TI - Standardization of radium-223 by liquid scintillation counting JO - Appl Radiat Isot VL - 68 UR - https://doi.org/10.1016/j.apradiso.2009.11.068 DO - 10.1016/j.apradiso.2009.11.068 ID - Cessna2010 ER - TY - JOUR AU - Zimmerman, B. E. AU - Bergeron, D. E. AU - Cessna, J. T. AU - Fitzgerald, R. AU - Pibida, L. PY - 2015 DA - 2015// TI - Revision of the NIST standard for (223) Ra: new measurements and review of 2008 data JO - J Res Natl Inst Stand Technol VL - 120 UR - https://doi.org/10.6028/jres.120.004 DO - 10.6028/jres.120.004 ID - Zimmerman2015 ER - TY - STD TI - Xofigo (radium Ra 223 dichloride) Injection [package insert]. Wayne (NJ): Bayer HealthCare Pharmaceuticals Inc. 2013. http://labeling.bayerhealthcare.com/html/products/pi/Xofigo_PI.pdf. UR - http://labeling.bayerhealthcare.com/html/products/pi/Xofigo_PI.pdf ID - ref24 ER - TY - JOUR AU - Eisenhauer, E. A. AU - Therasse, P. AU - Bogaerts, J. PY - 2009 DA - 2009// TI - New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) JO - Eur J Cancer VL - 45 UR - https://doi.org/10.1016/j.ejca.2008.10.026 DO - 10.1016/j.ejca.2008.10.026 ID - Eisenhauer2009 ER - TY - JOUR AU - Scher, H. I. AU - Halabi, S. AU - Tannock, I. PY - 2008 DA - 2008// TI - Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the prostate Cancer clinical trials working group JO - J Clin Oncol VL - 26 UR - https://doi.org/10.1200/JCO.2007.12.4487 DO - 10.1200/JCO.2007.12.4487 ID - Scher2008 ER - TY - JOUR AU - Antonarakis, E. S. AU - Feng, Z. AU - Trock, B. J. PY - 2012 DA - 2012// TI - The natural history of metastatic progression in men with prostate-specific antigen recurrence after radical prostatectomy: long-term follow-up JO - BJU Int VL - 109 UR - https://doi.org/10.1111/j.1464-410X.2011.10422.x DO - 10.1111/j.1464-410X.2011.10422.x ID - Antonarakis2012 ER - TY - JOUR AU - Keizman, D. AU - Zahurak, M. AU - Sinibaldi, V. PY - 2010 DA - 2010// TI - Lenalidomide in nonmetastatic biochemically relapsed prostate cancer: results of a phase I/II double-blinded, randomized study JO - Clin Cancer Res VL - 16 UR - https://doi.org/10.1158/1078-0432.CCR-10-1928 DO - 10.1158/1078-0432.CCR-10-1928 ID - Keizman2010 ER - TY - JOUR AU - Pound, C. R. AU - Partin, A. W. AU - Eisenberger, M. A. AU - Chan, D. W. AU - Pearson, J. D. AU - Walsh, P. C. PY - 1999 DA - 1999// TI - Natural history of progression after PSA elevation following radical prostatectomy JO - JAMA VL - 281 UR - https://doi.org/10.1001/jama.281.17.1591 DO - 10.1001/jama.281.17.1591 ID - Pound1999 ER - TY - JOUR AU - Kneebone, A. AU - Hruby, G. AU - Ainsworth, H. PY - 2018 DA - 2018// TI - Stereotactic body radiotherapy for Oligometastatic prostate Cancer detected via prostate-specific membrane antigen positron emission tomography JO - Eur Urol Oncol VL - 1 UR - https://doi.org/10.1016/j.euo.2018.04.017 DO - 10.1016/j.euo.2018.04.017 ID - Kneebone2018 ER - TY - JOUR AU - Siva, S. AU - Bressel, M. AU - Murphy, D. G. PY - 2018 DA - 2018// TI - Stereotactic Abative body radiotherapy (SABR) for Oligometastatic prostate Cancer: a prospective clinical trial JO - Eur Urol VL - 74 UR - https://doi.org/10.1016/j.eururo.2018.06.004 DO - 10.1016/j.eururo.2018.06.004 ID - Siva2018 ER - TY - JOUR AU - Moyer, C. L. AU - Phillips, R. AU - Deek, M. P. PY - 2019 DA - 2019// TI - Stereotactic ablative radiation therapy for oligometastatic prostate cancer delays time-to-next systemic treatment JO - World J Urol VL - 37 UR - https://doi.org/10.1007/s00345-018-2477-2 DO - 10.1007/s00345-018-2477-2 ID - Moyer2019 ER - TY - JOUR AU - Bleser, E. AU - Tran, P. T. AU - Ost, P. PY - 2017 DA - 2017// TI - Radiotherapy as metastasis-directed therapy for oligometastatic prostate cancer JO - Curr Opin Urol VL - 27 UR - https://doi.org/10.1097/MOU.0000000000000441 DO - 10.1097/MOU.0000000000000441 ID - Bleser2017 ER - TY - JOUR AU - Muldermans, J. L. AU - Romak, L. B. AU - Kwon, E. D. AU - Park, S. S. AU - Olivier, K. R. PY - 2016 DA - 2016// TI - Stereotactic body radiation therapy for Oligometastatic prostate Cancer JO - Int J Radiat Oncol Biol Phys VL - 95 UR - https://doi.org/10.1016/j.ijrobp.2016.01.032 DO - 10.1016/j.ijrobp.2016.01.032 ID - Muldermans2016 ER - TY - JOUR AU - Ost, P. AU - Jereczek-Fossa, B. A. AU - As, N. V. PY - 2016 DA - 2016// TI - Progression-free survival following stereotactic body radiotherapy for Oligometastatic prostate Cancer treatment-naive recurrence: a multi-institutional analysis JO - Eur Urol VL - 69 UR - https://doi.org/10.1016/j.eururo.2015.07.004 DO - 10.1016/j.eururo.2015.07.004 ID - Ost2016 ER - TY - JOUR AU - Decaestecker, K. AU - Meerleer, G. AU - Lambert, B. PY - 2014 DA - 2014// TI - Repeated stereotactic body radiotherapy for oligometastatic prostate cancer recurrence JO - Radiat Oncol VL - 9 UR - https://doi.org/10.1186/1748-717X-9-135 DO - 10.1186/1748-717X-9-135 ID - Decaestecker2014 ER - TY - JOUR AU - Ahmed, K. A. AU - Barney, B. M. AU - Davis, B. J. AU - Park, S. S. AU - Kwon, E. D. AU - Olivier, K. R. PY - 2012 DA - 2012// TI - Stereotactic body radiation therapy in the treatment of oligometastatic prostate cancer JO - Front Oncol VL - 2 UR - https://doi.org/10.3389/fonc.2012.00172 DO - 10.3389/fonc.2012.00172 ID - Ahmed2012 ER - TY - JOUR AU - Loi, M. AU - Cataldo, V. AU - Francolini, G. PY - 2018 DA - 2018// TI - Single-fraction stereotactic body radiotherapy for Oligometastatic lymph node relapse in prostate Cancer JO - Oncol Res Treat VL - 41 UR - https://doi.org/10.1159/000491605 DO - 10.1159/000491605 ID - Loi2018 ER - TY - JOUR AU - Markowski, M. C. AU - Imus, P. AU - Wright, J. L. AU - Schottenstein, D. AU - Paller, C. J. PY - 2017 DA - 2017// TI - Long-term control of Oligometastatic prostate Cancer after stereotactic body radiotherapy in the absence of androgen deprivation therapy: a case report JO - Clin Genitourin Cancer VL - 15 UR - https://doi.org/10.1016/j.clgc.2017.02.001 DO - 10.1016/j.clgc.2017.02.001 ID - Markowski2017 ER - TY - JOUR AU - Ingrosso, G. AU - Trippa, F. AU - Maranzano, E. PY - 2017 DA - 2017// TI - Stereotactic body radiotherapy in oligometastatic prostate cancer patients with isolated lymph nodes involvement: a two-institution experience JO - World J Urol VL - 35 UR - https://doi.org/10.1007/s00345-016-1860-0 DO - 10.1007/s00345-016-1860-0 ID - Ingrosso2017 ER - TY - JOUR AU - Pasqualetti, F. AU - Panichi, M. AU - Sainato, A. PY - 2016 DA - 2016// TI - [(18) F] Choline PET/CT and stereotactic body radiotherapy on treatment decision making of oligometastatic prostate cancer patients: preliminary results JO - Radiat Oncol VL - 11 UR - https://doi.org/10.1186/s13014-016-0586-x DO - 10.1186/s13014-016-0586-x ID - Pasqualetti2016 ER - TY - JOUR AU - Schick, U. AU - Jorcano, S. AU - Nouet, P. PY - 2013 DA - 2013// TI - Androgen deprivation and high-dose radiotherapy for oligometastatic prostate cancer patients with less than five regional and/or distant metastases JO - Acta Oncol VL - 52 UR - https://doi.org/10.3109/0284186X.2013.764010 DO - 10.3109/0284186X.2013.764010 ID - Schick2013 ER - TY - JOUR AU - Tosoian, J. J. AU - Gorin, M. A. AU - Ross, A. E. AU - Pienta, K. J. AU - Tran, P. T. AU - Schaeffer, E. M. PY - 2017 DA - 2017// TI - Oligometastatic prostate cancer: definitions, clinical outcomes, and treatment considerations JO - Nat Rev Urol VL - 14 UR - https://doi.org/10.1038/nrurol.2016.175 DO - 10.1038/nrurol.2016.175 ID - Tosoian2017 ER - TY - JOUR AU - Palma, D. A. AU - Olson, R. AU - Harrow, S. PY - 2019 DA - 2019// TI - Stereotactic ablative radiotherapy for the comprehensive treatment of 4-10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial JO - BMC Cancer VL - 19 UR - https://doi.org/10.1186/s12885-019-5977-6 DO - 10.1186/s12885-019-5977-6 ID - Palma2019 ER -